Your browser doesn't support javascript.
loading
Living vs deceased donor liver transplantation in cholestatic liver disease: An analysis of the OPTN database.
Ziogas, Ioannis A; Alexopoulos, Sophoclis P; Matsuoka, Lea K; Geevarghese, Sunil K; Gorden, Lee D; Karp, Seth J; Perkins, James D; Montenovo, Martin I.
Afiliación
  • Ziogas IA; Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Alexopoulos SP; Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Matsuoka LK; Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Geevarghese SK; Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Gorden LD; Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Karp SJ; Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Perkins JD; Division of Transplantation, Department of Surgery, University of Washington, Seattle, WA, USA.
  • Montenovo MI; Clinical and Bio-Analytics Transplant Laboratory (CBATL), University of Washington, Seattle, WA, USA.
Clin Transplant ; 34(10): e14031, 2020 10.
Article en En | MEDLINE | ID: mdl-33427333
ABSTRACT

BACKGROUND:

Living donor liver transplantation (LDLT) and donation after circulatory death (DCD) can expand the donor pool for cholestatic liver disease (CLD) patients. We sought to compare the outcomes of deceased donor liver transplant (DDLT) vs LDLT in CLD patients.

METHODS:

Retrospective cohort analysis of adult CLD recipients registered in the OPTN database who received primary LT between 2002 and 2018. Cox proportional hazards regression models with mixed effects were used to determine the impact of graft type on patient and graft survival.

RESULTS:

Five thousand, nine hundred ninety-nine DDLT (5730 donation after brain death [DBD], 269 DCD) and 912 LDLT recipients were identified. Ten-year patient/graft survival rates were DBD 73.8%/67.9%, DCD 74.7%/60.7%, and LDLT 82.5%/73.9%. Higher rates of biliary complications as a cause of graft failure were seen in DCD (56.8%) than LDLT (30.5%) or DBD (18.7%) recipients. On multivariable analysis, graft type was not associated with patient mortality, while DCD was independently associated with graft failure (P = .046).

CONCLUSION:

DBD, DCD, and LDLT were associated with comparable overall patient survival. No difference in the risk of graft failure could be observed between LDLT and DBD. DCD can be an acceptable alternative to DBD with equivalent patient survival, but inferior graft survival likely related to the high rate of biliary complications.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Obtención de Tejidos y Órganos / Trasplante de Hígado / Hepatopatías Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Clin Transplant Asunto de la revista: TRANSPLANTE Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Obtención de Tejidos y Órganos / Trasplante de Hígado / Hepatopatías Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Revista: Clin Transplant Asunto de la revista: TRANSPLANTE Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos